Keloid Treatment Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,995	248 Pages	Fairfield Market Research	January, 2025	FCSL19636241

Best Price Guarantee
Price	from $4,995
Length	248 Pages
Publisher	Fairfield Market Research
Published Date	January, 2025
SKU	FCSL19636241

The global market for keloid treatment is projected to expand steadily, with a CAGR of 4.02%. By 2025, the market is expected to reach USD 5.39 billion and further grow to USD 7.10 billion by 2032. The increasing prevalence of keloid formations, often due to genetic factors and rising numbers of surgical procedures, is a key contributor to market expansion. The demand for innovative treatment methods such as laser therapy, occlusive dressings, and intralesional corticosteroid injections is anticipated to rise significantly.

Market Insights

Keloids are excessive scar tissue growths that extend beyond the boundaries of the original wound. These occur due to excessive collagen production and can cause discomfort, itching, and aesthetic concerns. Various therapeutic options, including surgical removal, radiation therapy, and laser technology, are utilized to alleviate symptoms and improve cosmetic outcomes. However, due to variations in keloid response, achieving a standardized treatment remains a challenge. Companies are expanding their product portfolios through acquisitions, collaborations, and regulatory approvals. A notable advancement includes Avita Medical Inc. obtaining marketing authorization for the RECELL System in Japan. This milestone significantly enhances access to innovative keloid treatment solutions worldwide.

Market Drivers
• Increasing Cases of Keloid Formation: The growing number of skin injuries from surgical procedures, trauma, acne, and burns is leading to a higher incidence of keloids globally.
• Technological Advancements in Treatments: Breakthroughs in laser therapies, cryosurgery, and interferon-based treatments are improving the effectiveness of keloid management.
• Growing Focus on Aesthetic Concerns: Rising demand for non-invasive, effective treatments is driven by increasing awareness about skin appearance and scar prevention.
• Expanding Healthcare Infrastructure: Higher healthcare spending and favorable reimbursement policies are driving the market forward.

Business Opportunities
• Adoption of Cutting-Edge Technologies: Increased use of fractional lasers, pulsed dye lasers, and radiation therapy is revolutionizing keloid treatment methods.
• Investment in Research & Development: Leading companies are focusing on regenerative medicine and improved occlusive dressings to enhance treatment outcomes.
• Growth in Emerging Markets: Expanding healthcare accessibility in regions such as South Asia & Pacific is creating new opportunities for market players.

Regional Analysis
• North America: This region dominates the market due to its advanced healthcare facilities, widespread awareness, and the presence of top pharmaceutical and biotech companies focused on keloid treatments.
• Europe: Investments in research for scar management and advanced dermatological treatments are fueling growth in this region.
• Asia Pacific: Expected to witness the fastest growth, driven by increasing medical tourism, improved access to healthcare, and a rise in surgical procedures.
• Latin America & Middle East & Africa: These regions are gradually expanding their cosmetic surgery and dermatology sectors, providing new growth opportunities.

Key Players

Leading companies in the keloid treatment sector are actively engaging in partnerships, research, and product development to strengthen their market presence. Key market players include:
• Novartis AG
• Sensus Healthcare
• RXi Pharmaceuticals, Inc.
• Sonoma Pharmaceuticals, Inc.
• Perrigo Company plc
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International, Inc.
• Revitol Corporation
• Avita Medical Limited

Market Segmentation

The keloid treatment market is categorized by treatment type, end-user segments, and regional distribution:

By Treatment Type:
• Occlusive Dressing
• Compression Therapy
• Cryosurgery
• Excision
• Radiation Therapy
• Laser Therapy
• Interferon Therapy
• Intralesional Corticosteroid Injections
• Others

By End User:
• Hospitals
• Dermatology Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Please note: Delivery Timelines - 5 working days.

1. Executive Summary: 1.1. Global Keloid Treatment Market Snapshot; 1.2. Future Projections; 1.3. Key Market Trends; 1.4. Regional Snapshot, by Value and Volume, 2024; 1.5. Analyst Recommendations
2. Market Overview: 2.1. Market Definitions and Segmentations; 2.2. Market Dynamics; 2.2.1. Drivers; 2.2.2. Restraints; 2.2.3. Market Opportunities; 2.3. Value Chain Analysis; 2.4. Porter’s Five Forces Analysis; 2.5. COVID-19 Impact Analysis; 2.5.1. Supply; 2.5.2. Demand; 2.6. Impact of Ukraine-Russia Conflict; 2.7. Economic Overview; 2.7.1. World Economic Projections; 2.8. PESTLE Analysis
3. Global Keloid Treatment Market Outlook, 2019 - 2032: 3.1. Global Keloid Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032; 3.1.1. Key Highlights; 3.1.1.1. Occlusive Dressing; 3.1.1.2. Compression Therapy; 3.1.1.3. Cryosurgery; 3.1.1.4. Excision; 3.1.1.5. Radiation Therapy; 3.1.1.6. Laser Therapy; 3.1.1.7. Interferon Therapy; 3.1.1.8. Intralesional Corticosteroid Injections; 3.1.1.9. Others; 3.2. Global Keloid Treatment Market Outlook, by End User, Value (US$ Bn), 2019 - 2032; 3.2.1. Key Highlights; 3.2.1.1. Hospitals; 3.2.1.2. Dermatology Clinics; 3.2.1.3. Ambulatory Surgical Centers (ASCs); 3.2.1.4. Others; 3.3. Global Keloid Treatment Market Outlook, by Region, Value (US$ Bn), 2019 - 2032; 3.3.1. Key Highlights; 3.3.1.1. North America; 3.3.1.2. Europe; 3.3.1.3. Asia Pacific; 3.3.1.4. Latin America; 3.3.1.5. Middle East & Africa
4. North America Keloid Treatment Market Outlook, 2019 - 2032: 4.1. North America Keloid Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032; 4.1.1. Key Highlights; 4.1.1.1. Occlusive Dressing; 4.1.1.2. Compression Therapy; 4.1.1.3. Cryosurgery; 4.1.1.4. Excision; 4.1.1.5. Radiation Therapy; 4.1.1.6. Laser Therapy; 4.1.1.7. Interferon Therapy; 4.1.1.8. Intralesional Corticosteroid Injections; 4.1.1.9. Others; 4.2. North America Keloid Treatment Market Outlook, by End User, Value (US$ Bn), 2019 - 2032; 4.2.1. Key Highlights; 4.2.1.1. Hospitals; 4.2.1.2. Dermatology Clinics; 4.2.1.3. Ambulatory Surgical Centers (ASCs); 4.2.1.4. Others; 4.2.2. BPS Analysis/Market Attractiveness Analysis; 4.3. North America Keloid Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032; 4.3.1. Key Highlights; 4.3.1.1. U.S. Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 4.3.1.2. U.S. Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 4.3.1.3. Canada Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 4.3.1.4. Canada Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Keloid Treatment Market Outlook, 2019 - 2032: 5.1. Europe Keloid Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.1.1. Key Highlights; 5.1.1.1. Occlusive Dressing; 5.1.1.2. Compression Therapy; 5.1.1.3. Cryosurgery; 5.1.1.4. Excision; 5.1.1.5. Radiation Therapy; 5.1.1.6. Laser Therapy; 5.1.1.7. Interferon Therapy; 5.1.1.8. Intralesional Corticosteroid Injections; 5.1.1.9. Others; 5.2. Europe Keloid Treatment Market Outlook, by End User, Value (US$ Bn), 2019 - 2032; 5.2.1. Key Highlights; 5.2.1.1. Hospitals; 5.2.1.2. Dermatology Clinics; 5.2.1.3. Ambulatory Surgical Centers (ASCs); 5.2.1.4. Others; 5.2.2. BPS Analysis/Market Attractiveness Analysis; 5.3. Europe Keloid Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032; 5.3.1. Key Highlights; 5.3.1.1. Germany Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.2. Germany Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.1.3. U.K. Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.4. U.K. Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.1.5. France Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.6. France Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.1.7. Italy Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.8. Italy Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.1.9. Turkey Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.10. Turkey Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.1.11. Russia Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.12. Russia Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.1.13. Rest of Europe Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 5.3.1.14. Rest of Europe Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Keloid Treatment Market Outlook, 2019 - 2032: 6.1. Asia Pacific Keloid Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.1.1. Key Highlights; 6.1.1.1. Occlusive Dressing; 6.1.1.2. Compression Therapy; 6.1.1.3. Cryosurgery; 6.1.1.4. Excision; 6.1.1.5. Radiation Therapy; 6.1.1.6. Laser Therapy; 6.1.1.7. Interferon Therapy; 6.1.1.8. Intralesional Corticosteroid Injections; 6.1.1.9. Others; 6.2. Asia Pacific Keloid Treatment Market Outlook, by End User, Value (US$ Bn), 2019 - 2032; 6.2.1. Key Highlights; 6.2.1.1. Hospitals; 6.2.1.2. Dermatology Clinics; 6.2.1.3. Ambulatory Surgical Centers (ASCs); 6.2.1.4. Others; 6.2.2. BPS Analysis/Market Attractiveness Analysis; 6.3. Asia Pacific Keloid Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032; 6.3.1. Key Highlights; 6.3.1.1. China Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.3.1.2. China Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 6.3.1.3. Japan Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.3.1.4. Japan Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 6.3.1.5. South Korea Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.3.1.6. South Korea Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 6.3.1.7. India Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.3.1.8. India Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 6.3.1.9. Southeast Asia Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.3.1.10. Southeast Asia Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 6.3.1.11. Rest of Asia Pacific Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 6.3.1.12. Rest of Asia Pacific Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Keloid Treatment Market Outlook, 2019 - 2032: 7.1. Latin America Keloid Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032; 7.1.1. Key Highlights; 7.1.1.1. Occlusive Dressing; 7.1.1.2. Compression Therapy; 7.1.1.3. Cryosurgery; 7.1.1.4. Excision; 7.1.1.5. Radiation Therapy; 7.1.1.6. Laser Therapy; 7.1.1.7. Interferon Therapy; 7.1.1.8. Intralesional Corticosteroid Injections; 7.1.1.9. Others; 7.2. Latin America Keloid Treatment Market Outlook, by End User, Value (US$ Bn), 2019 - 2032; 7.2.1. Key Highlights; 7.2.1.1. Hospitals; 7.2.1.2. Dermatology Clinics; 7.2.1.3. Ambulatory Surgical Centers (ASCs); 7.2.1.4. Others; 7.2.2. BPS Analysis/Market Attractiveness Analysis; 7.3. Latin America Keloid Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032; 7.3.1. Key Highlights; 7.3.1.1. Brazil Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 7.3.1.2. Brazil Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 7.3.1.3. Mexico Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 7.3.1.4. Mexico Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 7.3.1.5. Argentina Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 7.3.1.6. Argentina Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 7.3.1.7. Rest of Latin America Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 7.3.1.8. Rest of Latin America Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Keloid Treatment Market Outlook, 2019 - 2032: 8.1. Middle East & Africa Keloid Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032; 8.1.1. Key Highlights; 8.1.1.1. Occlusive Dressing; 8.1.1.2. Compression Therapy; 8.1.1.3. Cryosurgery; 8.1.1.4. Excision; 8.1.1.5. Radiation Therapy; 8.1.1.6. Laser Therapy; 8.1.1.7. Interferon Therapy; 8.1.1.8. Intralesional Corticosteroid Injections; 8.1.1.9. Others; 8.2. Middle East & Africa Keloid Treatment Market Outlook, by End User, Value (US$ Bn), 2019 - 2032; 8.2.1. Key Highlights; 8.2.1.1. Hospitals; 8.2.1.2. Dermatology Clinics; 8.2.1.3. Ambulatory Surgical Centers (ASCs); 8.2.1.4. Others; 8.2.2. BPS Analysis/Market Attractiveness Analysis; 8.3. Middle East & Africa Keloid Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032; 8.3.1. Key Highlights; 8.3.1.1. GCC Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 8.3.1.2. GCC Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 8.3.1.3. South Africa Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 8.3.1.4. South Africa Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 8.3.1.5. Egypt Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 8.3.1.6. Egypt Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 8.3.1.7. Nigeria Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 8.3.1.8. Nigeria Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 8.3.1.9. Rest of Middle East & Africa Keloid Treatment Market by Treatment Type, Value (US$ Bn), 2019 - 2032; 8.3.1.10. Rest of Middle East & Africa Keloid Treatment Market by End User, Value (US$ Bn), 2019 - 2032; 8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape: 9.1. Company Market Share Analysis, 2024; 9.2. Competitive Dashboard; 9.3. Company Profiles; 9.3.1. Novartis AG; 9.3.1.1. Company Overview; 9.3.1.2. Product Portfolio; 9.3.1.3. Financial Overview; 9.3.1.4. Business Strategies and Development; 9.3.2. Sensus Healthcare; 9.3.2.1. Company Overview; 9.3.2.2. Product Portfolio; 9.3.2.3. Financial Overview; 9.3.2.4. Business Strategies and Development; 9.3.3. RXi Pharmaceuticals, Inc.; 9.3.3.1. Company Overview; 9.3.3.2. Product Portfolio; 9.3.3.3. Financial Overview; 9.3.3.4. Business Strategies and Development; 9.3.4. Sonoma Pharmaceuticals, Inc.; 9.3.4.1. Company Overview; 9.3.4.2. Product Portfolio; 9.3.4.3. Financial Overview; 9.3.4.4. Business Strategies and Development; 9.3.5. Perrigo Company plc.; 9.3.5.1. Company Overview; 9.3.5.2. Product Portfolio; 9.3.5.3. Financial Overview; 9.3.5.4. Business Strategies and Development; 9.3.6. Bristol-Myers Squibb Company; 9.3.6.1. Company Overview; 9.3.6.2. Product Portfolio; 9.3.6.3. Financial Overview; 9.3.6.4. Business Strategies and Development; 9.3.7. Pacific World Corporation; 9.3.7.1. Company Overview; 9.3.7.2. Product Portfolio; 9.3.7.3. Financial Overview; 9.3.7.4. Business Strategies and Development; 9.3.8. Valeant Pharmaceuticals International, Inc.; 9.3.8.1. Company Overview; 9.3.8.2. Product Portfolio; 9.3.8.3. Financial Overview; 9.3.8.4. Business Strategies and Development; 9.3.9. Revitol Corporation; 9.3.9.1. Company Overview; 9.3.9.2. Product Portfolio; 9.3.9.3. Financial Overview; 9.3.9.4. Business Strategies and Development; 9.3.10. Avita Medical Limited; 9.3.10.1. Company Overview; 9.3.10.2. Product Portfolio; 9.3.10.3. Financial Overview; 9.3.10.4. Business Strategies and Development
10. Appendix: 10.1. Research Methodology; 10.2. Report Assumptions; 10.3. Acronyms and Abbreviations

PDF E-mail From Publisher:	$4,995
Multi User License (2 - 5 Users):	$8,495
Global Site License Fulfilled by Publisher:	$10,600

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Keloid Treatment Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)

Collagen Supplements Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)

Dyslexia Treatments Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)

Rare Gastrointestinal Diseases Treatment Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Compan

Urinary Tract Infection (UTI) Treatment Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company

Lingerie Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)

Intravascular Imaging Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)

Research Assistance

Other tasks